Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
Logo Logo Logo Logo Logo Logo
  • Home
  • About Us
    • Organization
    • Members
    • Contact Us
  • Research & Publications
    • Therapeutics Letter
    • Drug Assessments
    • PharmacoEpidemiology
    • Blog
  • Prescribing Portraits
    • Register
  • Continuing Education
    • Events & Webinars
    • Podcasts & Videos
  • Subscribe
  • Donate
 

imipramine Tag

Study 329: Why is it so important?

22 Nov [101] Study 329: Why is it so important?

Posted at 17:20h in Therapeutics Letter 2 Comments
Share

Study 329 is a GlaxoSmithKline (GSK) sponsored trial with 22 academic authors that compared paroxetine, imipramine, and placebo for adolescent depression. In this trial 275 adolescents with major depression were randomized in a double-blind fashion...

Read More

adverse effects adverse events antibacterial agents antidepressive agents biosimilars blood pressure chronic obstructive pulmonary disease chronic pain COPD covid-19 deprescribing Deprescriptions Diabetes Diabetes Mellitus Drug-Related Side Effects and Adverse Reactions Drug Costs drug safety elderly empagliflozin gabapentin Glycemic Control guidelines hypertension hypoglycemic agents inappropriate prescribing Janus kinase inhibitor Mass Screening methods opioid analgesics opioids overdiagnosis pain pharmacoepidemiology polypharmacy portrait prescribing proton pump inhibitors psoriatic arthritis safety SGLT2 smoking cessation Sodium-Glucose Transporter 2 Inhibitors substance withdrawal syndrome tofacitinib tramadol

Therapeutics Initiative logo

Our mission is to provide physicians, nurse practitioners, pharmacists, allied health professionals, and the public with up-to-date, independent, evidence-based, practical information on healthcare interventions. More about us

The Therapeutics Initiative is part of the Department of Anesthesiology, Pharmacology & Therapeutics at UBC's Faculty of Medicine.

Donate

 

Contact

Therapeutics Initiative
Dept of Anesthesiology, Pharmacology & Therapeutics
Faculty of Medicine
University of British Columbia

300 - 2176 Health Sciences Mall
Vancouver, BC, Canada V6T 1Z3

210 - 1110 Government Street
Victoria, BC, Canada V8W 1Y2

Office: +1 604-822-0700
Send us a message

 

Subscribe for Updates

Want to stay abreast of new therapeutics information? Then subscribe to receive email notices of upcoming Therapeutics Letters, educational events, and other announcements. We promise not to spam you and you won’t hear from us more than a few times a month.

Subscribe

Located on the traditional, ancestral and unceded territory of the hən̓q̓əmin̓əm̓ speaking peoples, including the xʷməθkwəy̓əm (Musqueam), the Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh), and the Skwxwú7mesh (Squamish) Nations, and on the lək̓ʷəŋən (Lekwungen) territory of the Songhees, Esquimalt and W̱SÁNEĆ peoples.

 
© Copyright 1994 - 2022 Therapeutics Initiative | Terms & Policies